Yan CAO, PhD
About Yan CAO, PhD
Yan Cao, PhD, serves as the Vice President of Program Management at Deepcell, Inc. in Menlo Park, California, where he has worked since 2022, bringing extensive experience in genetics and genomics technologies from previous roles at various institutions.
Work at Deepcell
Currently, Yan Cao serves as the Vice President of Program Management at Deepcell, Inc., a position he has held since 2022. Deepcell is located in Menlo Park, California. In this role, he is responsible for overseeing program management initiatives, focusing on the integration of innovative technologies in the life sciences sector.
Previous Experience in Program Management
Before joining Deepcell, Yan Cao held several key positions in program management. He worked as the Head of Program Management at Invitae from 2014 to 2016. He also served as the Program Director for the Catalyst Program at UCSF Innovation Ventures from 2016 to 2018. His experience includes advising UCSF Innovation Ventures from 2018 to 2021, where he contributed to the development of innovative projects.
Education and Expertise
Yan Cao holds a Doctor of Philosophy (Ph.D.) in Pharmacology and Neuroscience from the University of Pennsylvania. He also studied Pre-Medicine at Peking University and completed a postdoctoral fellowship in Neurobiology at Stanford University. His educational background supports his extensive experience in genetics and genomics technologies, particularly in research and molecular diagnostics.
Career in Life Sciences
Yan Cao has a successful track record in life science portfolio, program, alliance, and product management. He has worked at notable organizations such as Twist Bioscience, where he served as Senior Director of Portfolio Program Management and General Manager of Twist China from 2018 to 2021. Additionally, he worked at Affymetrix Inc. as Associate Director of Product Development for nine years, contributing to advancements in the field.
Current Role at Roche
In addition to his role at Deepcell, Yan Cao is currently a Pharma Partnering and Operations Consultant at Roche Diagnostics, a position he has held since 2022. His work at Roche involves collaboration and operational management within the pharmaceutical sector, further enhancing his expertise in life sciences.